Reconval K1
Skin changes caused by the medication used to treat different types of cancer (colorectal cancer, head and neck cancer, lung cancer, pancreatic cancer, etc.) mainly occur in the form of rashes, reddening on the palms of the hands and the soles of the feet, eruptions in the form of acne, dry skin, changes on and around the nails, colouring and changes in the hair. Such side-effects are temporary and gradually wear off when the treatment is concluded. However, as treatment with targeted therapy drugs may last a long time, they also need to be alleviated. The changes to the skin may be mild or, in some cases, may cause discomfort to the patient and reduce their quality of life to such an extent that they abandon treatment with targeted therapy drugs. Since this has a negative effect on the treatment process and outcome, it is best to reduce the skin changes. Reconval K1 is a preparation containing vital ingredients that reduce skin changes caused by treatment with targeted therapy drugs. The cream can be bought in pharmacies without a prescription.
------------------------------------------
Reconval B6
A cream that relieves hand-foot syndrome and soothes inflamed skin caused by radiation therapy. Certain targeted therapy and classic cytostatic drugs, mainly drugs used to treat liver, colon, kidney, breast and ovarian cancer and chronic myeloid leukaemia, cause hand-foot syndrome. The skin changes mainly affect the hands and feet, hence the name "hand-foot syndrome". The skin on the hands and feet reddens, burns, may also break out in blisters and cracks and often peels. Such skin causes patients to have difficulty walking and picking things up. Although these side-effects only start to appear within seven to ten days after the first application of the drug and reach their peak a good thirty days after the beginning of treatment, it is advisable to start special skin care on the first day of treatment, thus helping to minimise the side-effects.